ライフサイエンスコーパス: abstainer

1 average 3 drinks/wk (compared with lifelong abstainers).

2 lower risk of coronary heart disease than do abstainers.

3 ed; and by initiating alcohol use in current abstainers.

4 .55 (CI, 0.90 to 2.68) compared with that of abstainers.

5 y consume moderate amounts of alcohol and in abstainers.

6 e lower rates of cardiovascular disease than abstainers.

7 rmance in many cognitive domains relative to abstainers.

8 cute cellular rejection in alcohol users and abstainers.

9 rognosis in posttransplant alcohol users and abstainers.

10 ntinued drinking were comparable to those of abstainers.

11 raction = 0.003) with lower risks in alcohol abstainers.

12 76 participants (42 successful abstainers, 34 smokers) were followed up.

13 sk factors compared with age-matched alcohol abstainers (A).

14 Compared with abstainers, alcohol intake of 5 to 14.9 g/d was associat

15 ifferences at the time of evaluation between abstainers and alcohol users in age, sex distribution, s

16 elapsers, while the opposite was observed in abstainers and healthy control subjects.

17 A(1c), with a better metabolic profile among abstainers and light drinkers who modestly increased the

18 y distributed between both alcohol users and abstainers and sometimes occurred in the absence of anti

19 13 abstainers and two smokers had an episode of major depre

20 d > 15 g alcohol/d had 93% greater risk than abstainers, and men who averaged > 2 pieces fruit/d had

21 mortality, even when compared with lifetime abstainers, but consumption above recommended limits was

22 Compared with abstainers, consumption of more than 60 g of alcohol per

23 Misclassification of lifelong abstainers could result in underestimation of harmful ef

24 at baseline was characterized into lifetime abstainers, former drinkers, and current drinkers of var

25 Of 20 prior abstainers from intercourse who completed the study, 17

26 sk of type 2 diabetes mellitus compared with abstainers (hazard ratio = 0.47, 95% confidence interval

27 ormer drinkers had a higher risk of CHF than abstainers (HR 1.51, p < 0.01), but those who quit durin

28 r recurrence or mortality risk compared with abstainers (HR, 0.48; 95% CI, 0.25 to 0.91; Ptrend = .00

29 On multivariable analysis, compared to abstainers, light and moderate alcohol use was not assoc

30 Compared with abstainers, light drinkers had a multivariate-adjusted r

31 hese differential results regarding lifetime abstainers may suggest bias from differential unmeasured

32 Compared with abstainers, moderate alcohol drinkers had higher plasma

33 first acute myocardial infarction (AMI) than abstainers or heavy drinkers, but the effect of prior dr

34 s compared with those for ADH1C*1 homozygote abstainers (P(trend) = 0.02).

35 Compared with abstainers, patients who consumed less than 7 drinks/wk

36 Compared with abstainers, risk was greatest among men who consumed an

37 ted; alcohol consumption was quantified; and abstainers served as the reference group.

38 a median age of 69 y at diagnosis, lifetime abstainers showed poorer overall [adjusted HR (aHR): 1.2

39 total alcohol-dependent group; however, the abstainers' slopes paralleled those of controls, whereas

40 Compared with lifetime abstainers, summary relative risks were 0.95 (95% confid

41 Compared with abstainers, the adjusted risk of CHF was lower among sub

42 Compared to abstainers, those who drank >/= 3 cups of caffeinated co

43 ose with intakes over 40 g/day compared with abstainers using a random-effects model (P for nonlinear

44 these data were used to construct groups of abstainers, very light, light, moderate, and heavy drink

45 e abnormally low FA, age trajectories of the abstainers were positive and progressing toward normalit

46 Clusters of drinkers and abstainers were present in the network at all time point

47 nderwent cessation treatment, and successful abstainers were re-examined by FDOPA-PET after 3 months

48 betes remained if light drinkers rather than abstainers were used as the reference group (RR = 0.60,

49 nfidence interval (CI) 1.1-6.4) greater than abstainers, while that for individuals who reported drin

50 ay) had the highest risk; in comparison with abstainers with a folate intake of 400-599 micro g/day,

51 Lifetime abstainers with nonmetastatic disease showed poorer CRC-

52 e CT genotype had lower SDMT scores than did abstainers with the CC genotype or moderate drinkers wit

53 However, women abstainers with the CT genotype had lower SDMT scores th